China bans Shenzhen hepatitis B vaccine
Updated: 2013-12-21 10:43
(Xinhua)
|
|||||||||
BEIJING - Chinese authorities on Friday issued a circular to ban the use of the recombinant hepatitis B vaccine produced by the Shenzhen-based BioKangtai company.
Chinese authorities on Friday issued a circular to ban the use of the recombinant hepatitis B vaccine produced by the Shenzhen-based BioKangtai company. [Photo by Xie Changgui / Asianewsphoto] |
The circular, jointly issued by the China Food and Drug Administration (CFDA) and the National Health and Family Planning Commission (NHFPC), said that four cases of infants' deaths were reported in Hunan, Guangdong and Sichuan provinces after inoculation using the vaccine.
The CFDA and the NHFPC will carry out further investigation into the cases and inspection over the company , the circular said.
Doctors check on an infant affected by the recombinant hepatitis B vaccine produced by the Shenzhen-based BioKangtai company, Dec 13, 2013. [Photo by Xie Changgui / Asianewsphoto] |
- China launches communications satellite for Bolivia
- ROK to return Chinese war dead
- Rodman trains basketball palyers in DPRK
- New York mulls banning e-cigarettes
- Climbers soar to new heights
- Reading China's future through its past
- Yanukovich offers Ukraine protesters nothing
- Former NBA player may coach in DPRK
Most Viewed
Editor's Picks
Taking a humane look at cosmetics |
Listening to the call of the wilderness |
Too young to be criminal |
Patrols bring security to Mekong River |
Skilled laborers go overseas |
Logging out of an Internet addiction |
Today's Top News
Obama nominates Baucus as ambassador to China
Tech bans to be relaxed: US
Chinese blasts Japan's defense move
China rejects US GM corn shipment
FDI enters new structural era
China, US start annual trade talks
New York mulls banning e-cigarettes
Verizon plans more data-request disclosures
US Weekly
Geared to go |
The place to be |